Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1216-1236
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1216
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1216
Figure 5 Expression of RON and PD-L1 in HT29 cells after treatment with 2 nmol/L MSP, 2 nmol/L MSP + 2 μmol/L BMS-777607, or 2 μmol/L BMS-777607.
A: Cellular immunofluorescence indicating the expression of RON and PD-L1 after treatment of HT29 cells with 2 nmol/L MSP, 2 nmol/L MSP + 2 μmol/L BMS-777607, or 2 μmol/L BMS-777607 for 24 h, respectively. DAPI indicates nuclei (blue color), FITC indicates PD-L1 (green color), and PE indicates RON (red color). Original magnification × 400 (all photomicrographs). B-C: HT29 cells were treated with 2 nmol/L MSP, 2 nmol/L MSP + 2 μmol/L BMS-777607, or 2 μmol/L BMS-777607 for 24 h, and the expression of RON and PD-L1 was detected by Western blot and quantified according to the immunoblots. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Liu YZ, Han DT, Shi DR, Hong B, Qian Y, Wu ZG, Yao SH, Tang TM, Wang MH, Xu XM, Yao HP. Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer. World J Gastrointest Oncol 2020; 12(11): 1216-1236
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1216.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1216